Profiel
Andrew B. Cubitt was the founder of AnaptysBio, Inc. since 2005, serving as Executive Director-Corporate Development from 2005 to 2009.
Dr. Cubitt is currently Vice President-External Scientific Alliances at aTyr Pharma, Inc. since 2011.
Former positions include Director-Intellectual Property at Ambit Biosciences Corp., Senior Manager-Technology & Intellectual Property at Aurora Biosciences Corp.
from 1996 to 2002, and Principal at X-Ceptor Therapeutics, Inc. from 2002 to 2013.
Education includes an undergraduate degree from the University of Birmingham conferred in 1984 and a doctorate from The University of Sheffield conferred in 1987.
Actieve functies van Andrew B. Cubitt
| Bedrijven | Functie | Begin |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01-09-2011 |
Eerdere bekende functies van Andrew B. Cubitt
| Bedrijven | Functie | Einde |
|---|---|---|
| ANAPTYSBIO, INC. | Oprichter | 01-07-2009 |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | 01-01-2002 |
| AMBIT BIOSCIENCES CORP | Corporate Officer/Principal | - |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Corporate Officer/Principal | - |
Opleiding van Andrew B. Cubitt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Ambit Biosciences Corp.
Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















